Equities researchers at JPMorgan Chase & Co. started coverage on shares of Dentsply International Inc. (NASDAQ:XRAY) in a report released on Thursday. The firm set a “neutral” rating on the stock.

Other equities analysts also recently issued reports about the stock. Credit Suisse Group AG reaffirmed a “buy” rating on shares of Dentsply International in a research note on Sunday, June 5th. Piper Jaffray Cos. reissued a “buy” rating on shares of Dentsply International in a research note on Monday, June 27th. Bank of America Corp. began coverage on shares of Dentsply International in a research note on Monday, September 12th. They issued a “buy” rating and a $70.00 price target for the company. Jefferies Group reissued a “buy” rating on shares of Dentsply International in a research note on Wednesday, August 17th. Finally, Zacks Investment Research downgraded shares of Dentsply International from a “buy” rating to a “hold” rating in a research note on Monday, August 8th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Dentsply International currently has a consensus rating of “Buy” and a consensus target price of $67.00.

Dentsply International (NASDAQ:XRAY) opened at 59.89 on Thursday. Dentsply International has a 52-week low of $49.48 and a 52-week high of $65.83. The firm’s 50 day moving average is $60.83 and its 200 day moving average is $61.57. The company has a market cap of $13.96 billion, a PE ratio of 28.10 and a beta of 1.40.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/dentsply-international-inc-xray-now-covered-by-jpmorgan-chase-co.html

Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.70 by $0.06. The firm earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Dentsply International had a net margin of 11.99% and a return on equity of 9.18%. The company’s quarterly revenue was up 46.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.73 earnings per share. Analysts forecast that Dentsply International will post $2.76 EPS for the current fiscal year.

In other news, SVP Maureen J. Macinnis sold 45,100 shares of the stock in a transaction that occurred on Thursday, August 25th. The shares were sold at an average price of $60.55, for a total transaction of $2,730,805.00. Following the sale, the senior vice president now owns 36,730 shares in the company, valued at $2,224,001.50. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, VP Rainer Berthan sold 5,000 shares of the stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total transaction of $305,600.00. Following the sale, the vice president now owns 34,370 shares in the company, valued at approximately $2,100,694.40. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Evercore Wealth Management LLC boosted its stake in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock worth $199,000 after buying an additional 358 shares during the last quarter. Carnick & Kubik Group LLC purchased a new stake in Dentsply International during the second quarter worth approximately $258,000. Williams Jones & Associates LLC boosted its stake in Dentsply International by 84.1% in the second quarter. Williams Jones & Associates LLC now owns 970,261 shares of the company’s stock worth $60,195,000 after buying an additional 443,353 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in Dentsply International during the second quarter worth approximately $587,000. Finally, Kentucky Retirement Systems purchased a new stake in Dentsply International during the second quarter worth approximately $1,236,000. Hedge funds and other institutional investors own 94.58% of the company’s stock.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.